References
- Eby N.L., Grufferman S., Flannely C.M., Schold S.C., Jr., Vogel F.S., Burger P.C. Increasing incidence of primary brain lymphoma in the US. Cancer 1988; 62: 2461–2465
- Murray K., Kun L., Cox J. Primary malignant lymphoma of the central nervous system. J Neurosurg 1986; 65: 600–607
- Nelson D.F., Martz K.L., Bonner H., Nelson J.S., Newall J., Kerman H.D., Thomson J.W., Murray K.J. Non-Hodgkin's Lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Rad Oncol Biol Phys 1992; 23: 9–17
- Levitt L.J., Dawson D.M., Rosenthal D.S., Moloney W.C. CNS involvement in the Non-Hodgkin's lymphomas. Cancer 1980; 45: 545–552
- Liang R.H.S., Woo E.K.W., Yu Y.L., Todd D., Chan T.K., Ho F.C.S., Tso S.C., Shum J.S.T. Central nervous system involvement in non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol 1989; 25(4)703–710
- Mead G.M., Kennedy P., Smith J.L., Thompson J., Macbeth F.R.M., Ryall R.D. Involvement of the central nervous system by non-Hodgkin's lymphoma in adults, a review of 36 cases. Q J Med 1986; 60: 699–714
- MacKintosh F.R., Colby T.V., Podolsky W.J., Burke J.S., Hoppe R.T., Rosenfeld F.P., Rosenberg S.A., Kaplan H.S. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer 1982; 49: 586–595
- DeAngelis L.M., Yahalom J., Thaler H.T., Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635–643
- Chamberlain M.C., Levin V.A. Primary central nervous system lymphoma: a role for adjuvant chemotherapy. J Neurooncol 1992; 14: 271–275
- Gabbai A.A., Hochberg F.H., Lingood R. High dose methotrexate therapy of primary brain lymphoma. J Neurosurg 1989; 70: 190–194
- Bessell E.M., Graus F., Punt J.A.G., Firth J.L., Hope D.T., Moloney A.J., Lopez-Guillermo A., Villa S. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J Clin Oncol 1996; 14: 945–954
- Freilich R.J., Delattre J.Y., Monjour A., DeAngelis L.M. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 1996; 46: 435–439
- Neuwelt E.A., Goldman D.L., Dahlborg S.A., Crossen J., Ramsey F., Roman-Goldstein S., Braziel R., Dana B. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991; 9: 1580–1590
- Thiel E., Korfel A. Successful treatment of Non-Hodgkin's lymphoma of the CNS with the BMPD chemotherapy protocol followed by radiotherapy. Experimental Hematology 1997; 25(8)846
- Chabner B.A., Stoller R.G., Hande K.R., Jacobs S., Young R.C. Methotrexate disposition in humans: Case studies in ovarian cancer and following high-dose infusion. Drug Metab Rev 1978; 8: 107–117
- Schultz C., Scott C., Sherman W., Donahue B., Fields J., Murray K., Fisher B., Abrams R., Meis-Kindblom J. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphoma: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 1996; 14(2)556–564
- Lachance D.H., Brizel D.M., Gockerman J.P., Helperin E.C., Burger P.C., Boyko O.B., Brown M.T., Schold S.C., Jr. Cyclophosphamide, doxorubicin, vincristine and prednisolone for primary central nervous system lymphoma. Short duration response and multifocal intracerebral recurrence preceding radiotherapy. Neurology 1994; 44: 1721–1727
- Pitman S.W., Frei E. Weekly methotrexate-calcium leucovorin rescue; effect of alkalinisation on nephrotoxicity, pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat Rep 1977; 61: 695–701
- Shapiro W.R., Young D.F., Mehta B.M. Methotrexate: distribution in cerebrospinal fluid after intravenous ventricular and lumbar injections. N Engl J Med 1975; 293: 161–166
- Cher L., Glass J., Harsh G.R., Hochberg F.H. Therapy of primary CNS lymphoma with methotrexate based chemotherapy and deferred radiotherapy: Preliminary results. Neurology 1996; 46: 1757–1759